In support of these clinical evidences, immunohistochemical findings suggest that ALS may affect the frontotemporal network and, furthermore, is considered part of a broader clinicopathological spectrum now known as TAR-DNA binding protein 43 (TDP-43) proteinopathies which also include FTD [6, 7]. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.